Sg Americas Securities, LLC Cara Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.52 - $1.05 $29,182 - $58,926	-56,120 Reduced 77.82%	15,992 $15,000
Q4 2023 Jan 12, 2024	BUY	$0.6 - $1.65 $2,494 - $6,860	4,158 Added 6.12%	72,112 $54,000
Q3 2023 Oct 13, 2023	BUY	$1.67 - $3.33 $30,096 - $60,013	18,022 Added 36.09%	67,954 $114,000
Q2 2023 Jul 10, 2023	SELL	$2.83 - $4.94 $71,132 - $124,166	-25,135 Reduced 33.48%	49,932 $141,000
Q1 2023 Apr 28, 2023	BUY	$4.89 - $12.27 $132,030 - $331,290	27,000 Added 56.17%	75,067 $369,000
Q4 2022 Feb 02, 2023	BUY	$8.88 - $12.77 $15,104 - $21,721	1,701 Added 3.67%	48,067 $516,000
Q3 2022 Oct 31, 2022	SELL	$8.24 - $12.56 $153,033 - $233,264	-18,572 Reduced 28.6%	46,366 $434,000
Q2 2022 Jul 29, 2022	SELL	$7.45 - $13.84 $77,442 - $143,866	-10,395 Reduced 13.8%	64,938 $593,000
Q1 2022 Apr 29, 2022	SELL	$9.94 - $12.65 $158,761 - $202,045	-15,972 Reduced 17.49%	75,333 $915,000
Q4 2021 Feb 07, 2022	SELL	$11.99 - $18.14 $17,313 - $26,194	-1,444 Reduced 1.56%	91,305 $1.11 Million
Q3 2021 Nov 01, 2021	BUY	$11.55 - $16.06 $740,158 - $1.03 Million	64,083 Added 223.55%	92,749 $1.43 Million
Q2 2021 Aug 12, 2021	SELL	$12.38 - $29.19 $318,995 - $752,138	-25,767 Reduced 47.34%	28,666 $409,000
Q1 2021 May 13, 2021	SELL	$15.07 - $21.71 $1.45 Million - $2.09 Million	-96,468 Reduced 63.93%	54,433 $1.18 Million
Q4 2020 Feb 04, 2021	BUY	$12.72 - $16.16 $226,505 - $287,761	17,807 Added 13.38%	150,901 $2.28 Million
Q3 2020 Nov 09, 2020	BUY	$12.34 - $17.92 $205,633 - $298,618	16,664 Added 14.31%	133,094 $1.69 Million
Q2 2020 Jul 20, 2020	BUY	$12.39 - $17.33 $1.08 Million - $1.51 Million	87,375 Added 300.72%	116,430 $1.99 Million
Q1 2020 Apr 30, 2020	BUY	$9.12 - $17.78 $97,100 - $189,303	10,647 Added 57.84%	29,055 $384,000
Q4 2019 Jan 28, 2020	BUY	$16.11 - $25.98 $73,606 - $118,702	4,569 Added 33.02%	18,408 $297,000
Q3 2019 Nov 04, 2019	SELL	$18.28 - $26.91 $272,755 - $401,524	-14,921 Reduced 51.88%	13,839 $253,000
Q2 2019 Jul 29, 2019	BUY	$17.68 - $21.57 $161,966 - $197,602	9,161 Added 46.74%	28,760 $618,000
Q1 2019 Apr 29, 2019	SELL	$14.41 - $19.64 $1.26 Million - $1.71 Million	-87,134 Reduced 81.64%	19,599 $385,000
Q4 2018 Feb 01, 2019	BUY	$12.45 - $23.47 $1.33 Million - $2.51 Million	106,733 New	106,733 $1.39 Million
Q4 2017 Jan 24, 2018	SELL	$11.86 - $14.08 $300,686 - $356,970	-25,353 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$12.6 - $16.34 $319,447 - $414,268	25,353	25,353 $347,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$607,205
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$459,569
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$420,187
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$300,521
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$299,411
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account